HR 6660
116th Congress
House
Health
Administrative law and regulatory procedures
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Government information and archives
Government studies and investigations
Health technology, devices, supplies
Manufacturing
Prescription drugs
LOSS Act of 202
Introduced: May 1, 2020
Introduced by:
Blunt Rochester, Lisa
Democratic
· Delaware
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 1, 2020
Referred to the House Committee on Energy and Commerce.
May 1, 2020
Introduced in House
Plain-English summary
Limit Ongoing Shortages and Stabilize Supply Act of 2020 or the LOSS Act of 2020
This bill addresses drug shortages, including by requiring drug manufacturers to conduct risk assessments and implement risk-mitigation plans with respect to such shortages.
What's happening now
Referred to the House Committee on Energy and Commerce.
Committees of jurisdiction
1